Ingersoll Rand INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Ingersoll Rand announced robust second quarter 2026 financial results, driven by strong organic growth and effective execution.
NYSE
Ingersoll Rand stockholders approved the 2026 Omnibus Incentive Plan and re-elected the Board of Directors at the 2026 Annual Meeting.
NYSE
Ingersoll Rand announced first quarter 2026 financial results, demonstrating solid performance with growth in orders and revenue, while maintaining full-year guidance.
NYSE
Ingersoll Rand Inc. announced the appointment of former Tesla President Jerome Guillen to its Board of Directors, effective January 1, 2026, expanding the board to ten members.
NYSE
Ingersoll Rand Inc. announced strong financial results for the third quarter of 2025, driven by robust orders and revenue growth across both segments.
NYSE
Ingersoll Rand Inc. announced record second quarter 2025 orders, revenues, and adjusted EBITDA, while raising its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS, despite reporting a net loss primarily due to non-cash impairments.
NYSE
Ingersoll Rand Inc. announced the appointment of Aurobind Satpathy, a senior partner at McKinsey & Company, to its Board of Directors, effective July 15, 2025, and reset the Board size to nine directors.
NYSE
Ingersoll Rand Inc. announced an expanded role for Michael Weatherred to lead its Precision & Science Technologies segment, alongside significant compensation adjustments for both Mr. Weatherred and General Counsel Andrew Schiesl, effective June 2025.
NYSE
Ingersoll Rand Inc. announced the successful election of all director nominees, ratification of Deloitte & Touche LLP as its independent auditor, and advisory approval of executive compensation at its 2025 annual meeting of stockholders.
NYSE
Ingersoll Rand announced strong first-quarter 2025 results, marked by record orders, revenue, and free cash flow, driven by its competitive differentiator Ingersoll Rand Execution Excellence (IRX).
NYSE
Ingersoll Rand Inc. appoints Michelle Swanenburg, Head of HR at T. Rowe Price, to its Board of Directors, effective immediately.
NYSE
Julie A. Schertell resigned from Ingersoll Rand's Board of Directors and related committees, effective March 27, 2025.
NYSE
Ingersoll Rand announced record fourth quarter and full-year 2024 results, driven by strong execution and performance, and anticipates continued revenue and earnings growth in 2025.
NYSE
Ingersoll Rand announced record third-quarter 2024 results, with significant growth in orders, revenue, and profitability, driven by its Ingersoll Rand Execution Excellence (IRX) program and strategic acquisitions.
NYSE
Ingersoll Rand granted additional equity awards to its CFO and Senior Vice President of IR Execution Excellence to ensure market-competitive compensation.
NYSE
Ingersoll Rand has established a commercial paper program allowing for the issuance of up to $2.6 billion in short-term debt to provide additional financing flexibility.
NYSE
Ingersoll Rand reported record second-quarter revenue, adjusted EBITDA, and adjusted EPS, leading to an increased full-year guidance.
NYSE
Ingersoll Rand Inc. successfully held its 2024 annual meeting, electing directors, ratifying its auditor, and approving executive compensation.
NYSE
Ingersoll Rand has divested its legacy asbestos liabilities by selling its wholly-owned subsidiaries to Delticus for $188.5 million, removing these liabilities from its balance sheet.
NYSE
Ingersoll Rand's CEO, Vicente Reynal, sold 213,200 net shares after exercising vested stock options, while maintaining significant holdings in the company.
NYSE
Ingersoll Rand successfully finalized a $3.3 billion senior unsecured bond offering and a new $2.6 billion senior unsecured revolving credit facility, enhancing its financial profile.
NYSE
Ingersoll Rand reported record first-quarter revenue, adjusted EBITDA, and adjusted EPS, leading to an increase in full-year guidance.
NYSE
Ingersoll Rand has agreed to acquire ILC Dover for $2.325 billion in cash, plus a potential earnout, to expand its presence in the life sciences sector.
NYSE
Ingersoll Rand reported record fourth-quarter and full-year 2023 results, driven by strong orders and revenue growth, and provided a robust outlook for 2024.